Top Markets
Coin of the day
Cryosite Limited Cryosite Limited

Cryosite Limited

CTE
Kedudukan dalam Saham #26140
Cryosite Limited, founded in 1999 and headquartered in South Granville,... Cryosite Limited, founded in 1999 and headquartered in South Granville, Australia, specializes in providing outsourced logistics and storage solutions to the life sciences industry within Australia. The company operates through two distinct divisions. Its Clinical Trials and Biological Services Logistics segment offers comprehensive support to the clinical research and pharmaceutical sectors, encompassing services such as specialized temperature-controlled and general biological storage, precise labeling, secondary packaging, and end-to-end supply chain management capabilities like scheduled drug distribution, returns processing, material destruction, status oversight, comparator sourcing, and validated import/export and transportation. The second division, Cord Blood and Tissues Storage, focuses on the long-term cryogenic preservation of cord blood and tissue samples. Cryosite's client base spans the research, medical, pharmaceutical, veterinary, and biotechnology industries.
Harga Saham
$0.881606
Disegerakkan terakhir: 2026-08-12
Modal Pasaran
$43.03M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
81.49%
Negara
AU
Perdagangan Cryosite Limited (CTE)

Kategori

Pendapatan untuk Cryosite Limited (CTE)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Cryosite Limited, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Cryosite Limited dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.58B -
US